FIELD: medicine. SUBSTANCE: method involves determining chemical kinetic capacity of neutrophils in peripheral blood taken from a patient, calculating neutrophil percentage for those possessing ameba-like cytoplasm bulging. If the number of modified neutrophils is less than 11% minimum activity is diagnosed, the value exceeding 11% moderate activity is diagnosed, the value being higher than 28% high activity of inflammatory process is diagnosed. EFFECT: enhanced accuracy of diagnosis.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DEVELOPING DIFFERENTIAL DIAGNOSIS OF CHRONIC PERSISTENT HEPATITIS AND HEPATIC CIRRHOSIS | 1992 |
|
RU2068565C1 |
| METHOD OF LEOKOSIS COURSE PROGNOSIS | 1991 |
|
RU2069858C1 |
| METHOD OF DIFFERENTIAL DIAGNOSIS OF CHRONIC MYELOPROLIFERATIVE DISEASES | 1992 |
|
RU2063034C1 |
| METHOD FOR FORECASTING LEUKOSIS COURSE | 1992 |
|
RU2049997C1 |
| METHOD OF ESTIMATING RESISTANCE OF LEUCOCYTES IN LEUCOSIS | 0 |
|
SU1774222A1 |
| METHOD FOR DETERMINING THE NEUTROPHILIC ACTIVITY | 0 |
|
SU1713557A1 |
| METHOD FOR DETERMINATION OF INDIVIDUAL SENSITIVITY TO IMMUNOMODULATOR | 0 |
|
SU1658094A1 |
| METHOD OF ESTIMATION OF ORGANISM RESISTANCE DECREASE TO INFECTION IN LEUKOSIS PATIENTS | 1992 |
|
RU2063041C1 |
| METHOD OF DETERMINATION OF NONSPECIFIC ANTIBACTERIAL ORGANISM RESISTANCE | 1992 |
|
RU2068997C1 |
| METHOD OF DIAGNOSIS OF LYMPHOLEUKOSIS CHRONIC FORMS | 1992 |
|
RU2068995C1 |
